These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29563525)

  • 1. Investigating the state dependence of drug binding in hERG channels using a trapped-open channel phenotype.
    Thouta S; Lo G; Grajauskas L; Claydon T
    Sci Rep; 2018 Mar; 8(1):4962. PubMed ID: 29563525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of hERG channel block by terfenadine and cisapride.
    Kamiya K; Niwa R; Morishima M; Honjo H; Sanguinetti MC
    J Pharmacol Sci; 2008 Nov; 108(3):301-7. PubMed ID: 18987434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
    Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
    Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.
    Lin J; Guo J; Gang H; Wojciechowski P; Wigle JT; Zhang S
    Mol Pharmacol; 2005 Sep; 68(3):855-65. PubMed ID: 15967876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State dependent dissociation of HERG channel inhibitors.
    Stork D; Timin EN; Berjukow S; Huber C; Hohaus A; Auer M; Hering S
    Br J Pharmacol; 2007 Aug; 151(8):1368-76. PubMed ID: 17592502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
    Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
    Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular potassium dependency of block of HERG by quinidine and cisapride is primarily determined by the permeant ion and not by inactivation.
    Barrows B; Cheung K; Bialobrzeski T; Foster J; Schulze J; Miller A
    Channels (Austin); 2009; 3(4):239-48. PubMed ID: 19617705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
    Roy M; Dumaine R; Brown AM
    Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature Dependence of the Biophysical Mechanisms Underlying the Inhibition and Enhancement Effect of Amiodarone on hERG Channels.
    Lo YC; Kuo CC
    Mol Pharmacol; 2019 Sep; 96(3):330-344. PubMed ID: 31253645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
    Mohammad S; Zhou Z; Gong Q; January CT
    Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation.
    Ulens C; Tytgat J
    FEBS Lett; 2000 May; 474(1):111-5. PubMed ID: 10828461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
    Guo J; Gang H; Zhang S
    J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants for high-affinity block of hERG potassium channels.
    Mitcheson J; Perry M; Stansfeld P; Sanguinetti MC; Witchel H; Hancox J
    Novartis Found Symp; 2005; 266():136-50; discussion 150-8. PubMed ID: 16050266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
    Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a new mexiletine-derived agonist of the hERG K
    Gualdani R; Cavalluzzi MM; Tadini-Buoninsegni F; Lentini G
    Biophys Chem; 2017 Oct; 229():62-67. PubMed ID: 28673509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.